Seres Therapeutics, Inc.MCRBEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

Seres Therapeutics is a clinical-stage biotechnology company focused on developing novel microbiome-based therapeutic medicines. It targets unmet needs across infectious, inflammatory, and metabolic disease areas, with lead candidates for recurrent Clostridioides difficile infection. It operates primarily in the U.S. and partners with global pharma firms to advance its pipeline.